Expanded Access and Post-Trial Access Programs are inherently complex. Even the most carefully designed initiatives can face unforeseen challenges as they progress. In these moments, Sponsors need a trusted partner to take over, that can stabilize operations, restore momentum, and ensure that patients continue to receive critical treatments without interruption.
At WEP Clinical, we specialize in guiding programs through these transitions. Our team brings together regulatory expertise, operational excellence, and a patient-first mindset to transform struggling programs into streamlined, compliant, and sustainable solutions.
Our Approach to Seamless Transitions
When Sponsors transition a program to WEP Clinical, our priority is to make the process as seamless as possible. Continuity is critical, for patients, for physicians, and for Sponsor teams. Our structured transition model emphasizes:
- Transparency – open, consistent communication at every stage
- Collaboration – close partnership with Sponsors, sites, and stakeholders
- Stability – processes that ensure minimal disruption and uninterrupted treatment
The case studies in the table below highlight how WEP Clinical has provided rescue support across a variety of therapeutic areas and geographies. Each example demonstrates how we applied tailored solutions to resolve challenges, maintain continuity, and deliver renewed confidence for Sponsors, sites, and physicians.
Conclusion
By focusing on solutions, not setbacks, WEP Clinical has built a reputation for rescuing programs and restoring Sponsor trust. Our expertise enables us to unlock value, strengthen compliance, and keep patients at the center of every decision.
If your access program could benefit from additional expertise, proactive problem-solving, and patient-centered execution, WEP Clinical is ready to help you move forward with confidence.
📩 Contact us: EAP@WEPCLINICAL.COM
